PDB Short entry for 2VIK HEADER ACTIN-BINDING PROTEIN 16-JAN-97 2VIK TITLE REFINED STRUCTURE OF THE ACTIN-SEVERING DOMAIN VILLIN 14T, DETERMINED TITLE 2 BY SOLUTION NMR, MINIMIZED AVERAGE STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: VILLIN 14T; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1 - 126; COMPND 5 SYNONYM: VILLIN DOMAIN 1, VILLIN SEGMENT 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 CELL_LINE: BL21; SOURCE 6 ORGAN: INTESTINE; SOURCE 7 CELL: EPITHELIAL CELLS; SOURCE 8 GENE: T7; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: BACTERIAL; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PAED4, BASED ON T7 PROMOTER; SOURCE 14 EXPRESSION_SYSTEM_GENE: T7 KEYWDS ACTIN-BINDING PROTEIN, CAPPING PROTEIN, CALCIUM-BINDING PROTEIN, KEYWDS 2 CYTOSKELETAL PROTEIN EXPDTA SOLUTION NMR AUTHOR M.A.MARKUS,P.MATSUDAIRA,G.WAGNER REVDAT 3 29-NOV-17 2VIK 1 REMARK HELIX REVDAT 2 24-FEB-09 2VIK 1 VERSN REVDAT 1 01-APR-97 2VIK 0 JRNL AUTH M.A.MARKUS,P.MATSUDAIRA,G.WAGNER JRNL TITL REFINED STRUCTURE OF VILLIN 14T AND A DETAILED COMPARISON JRNL TITL 2 WITH OTHER ACTIN-SEVERING DOMAINS. JRNL REF PROTEIN SCI. V. 6 1197 1997 JRNL REFN ISSN 0961-8368 JRNL PMID 9194180 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.MARKUS,K.T.DAYIE,P.MATSUDAIRA,G.WAGNER REMARK 1 TITL LOCAL MOBILITY WITHIN VILLIN 14T PROBED VIA HETERONUCLEAR REMARK 1 TITL 2 RELAXATION MEASUREMENTS AND A REDUCED SPECTRAL DENSITY REMARK 1 TITL 3 MAPPING REMARK 1 REF BIOCHEMISTRY V. 35 1722 1996 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.A.MARKUS,T.NAKAYAMA,P.MATSUDAIRA,G.WAGNER REMARK 1 TITL SOLUTION STRUCTURE OF VILLIN 14T, A DOMAIN CONSERVED AMONG REMARK 1 TITL 2 ACTIN-SEVERING PROTEINS REMARK 1 REF PROTEIN SCI. V. 3 70 1994 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.A.MARKUS,T.NAKAYAMA,P.MATSUDAIRA,G.WAGNER REMARK 1 TITL 1H, 15N, 13C AND 13CO RESONANCE ASSIGNMENTS AND SECONDARY REMARK 1 TITL 2 STRUCTURE OF VILLIN 14T, A DOMAIN CONSERVED AMONG REMARK 1 TITL 3 ACTIN-SEVERING PROTEINS REMARK 1 REF J.BIOMOL.NMR V. 4 553 1994 REMARK 1 REFN ISSN 0925-2738 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VIK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178733. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 4.15 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : DGII, IN INSIGHT II II REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NOE VIOLATIONS < 0.5 A DIHEDRAL REMARK 210 VIOL < 5 DEGREES REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 2 75.89 40.20 REMARK 500 SER A 4 151.07 -43.34 REMARK 500 LYS A 5 -72.80 80.07 REMARK 500 VAL A 7 -72.07 -151.51 REMARK 500 THR A 15 105.78 -170.02 REMARK 500 ASN A 25 27.04 42.32 REMARK 500 PRO A 32 -159.57 -77.60 REMARK 500 TYR A 40 147.85 -39.21 REMARK 500 ASP A 43 -145.26 -163.10 REMARK 500 LYS A 67 92.58 -38.74 REMARK 500 ASN A 68 -46.11 -162.76 REMARK 500 SER A 69 -158.47 -60.87 REMARK 500 SER A 90 -0.69 76.06 REMARK 500 SER A 103 -106.67 -47.63 REMARK 500 GLN A 112 -77.64 -173.90 REMARK 500 LYS A 117 -169.31 -79.97 REMARK 500 SER A 123 -73.58 -67.31 REMARK 500 MET A 125 -69.03 -156.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 22 0.27 SIDE CHAIN REMARK 500 ARG A 51 0.11 SIDE CHAIN REMARK 500 ARG A 96 0.32 SIDE CHAIN REMARK 500 ARG A 107 0.20 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CENTER OF ACTIN MONOMER BINDING SITE, BASED ON REMARK 800 COMPARISON WITH THE GELSOLIN SEGMENT 1-ACTIN COCRYSTAL (CENTERED REMARK 800 ON ILE 79). REMARK 800 REMARK 800 SITE_IDENTIFIER: CA1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SIDE CHAINS THAT PROVIDE LIGANDS TO CALCIUM IN REMARK 800 THE STRONGER BINDING SITE, BASED ON COMPARISON TO GELSOLIN REMARK 800 SEGMENT 1 AND CALCIUM TITRATIONS MONITORED BY NMR. NOTE THIS REMARK 800 CORRESPONDS TO THE INTRAMOLECULAR SITE IN THE GELSOLIN SEGMENT 1- REMARK 800 ACTIN CO-CRYSTAL (ASP 43, GLU 73). REMARK 800 REMARK 800 SITE_IDENTIFIER: CA2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: SIDE CHAIN THAT PROVIDES LIGANDS TO CALCIUM IN REMARK 800 THE WEAKER BINDING SITE, BASED ON COMPARISON TO GELSOLIN SEGMENT REMARK 800 1 AND CALCIUM TITRATIONS MONITORED BY NMR. NOTE THIS CORRESPONDS REMARK 800 TO THE INTERMOLECULAR SITE IN THE GELSOLIN SEGMENT 1-ACTIN CO- REMARK 800 CRYSTAL (ASP 85). REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VIL RELATED DB: PDB DBREF 2VIK A 1 126 UNP P02640 VILI_CHICK 2 127 SEQRES 1 A 126 VAL GLU LEU SER LYS LYS VAL THR GLY LYS LEU ASP LYS SEQRES 2 A 126 THR THR PRO GLY ILE GLN ILE TRP ARG ILE GLU ASN MET SEQRES 3 A 126 GLU MET VAL PRO VAL PRO THR LYS SER TYR GLY ASN PHE SEQRES 4 A 126 TYR GLU GLY ASP CYS TYR VAL LEU LEU SER THR ARG LYS SEQRES 5 A 126 THR GLY SER GLY PHE SER TYR ASN ILE HIS TYR TRP LEU SEQRES 6 A 126 GLY LYS ASN SER SER GLN ASP GLU GLN GLY ALA ALA ALA SEQRES 7 A 126 ILE TYR THR THR GLN MET ASP GLU TYR LEU GLY SER VAL SEQRES 8 A 126 ALA VAL GLN HIS ARG GLU VAL GLN GLY HIS GLU SER GLU SEQRES 9 A 126 THR PHE ARG ALA TYR PHE LYS GLN GLY LEU ILE TYR LYS SEQRES 10 A 126 GLN GLY GLY VAL ALA SER GLY MET LYS HELIX 1 A1 LEU A 3 LYS A 10 1 8 HELIX 2 A2 GLN A 71 LEU A 88 1 18 HELIX 3 A3 SER A 103 TYR A 109 1 7 SHEET 1 CEN 5 VAL A 29 VAL A 31 0 SHEET 2 CEN 5 GLY A 17 ILE A 23 -1 N ARG A 22 O VAL A 29 SHEET 3 CEN 5 CYS A 44 LYS A 52 -1 N LEU A 48 O GLN A 19 SHEET 4 CEN 5 PHE A 57 LEU A 65 -1 N HIS A 62 O LEU A 47 SHEET 5 CEN 5 GLN A 94 VAL A 98 1 O HIS A 95 N TYR A 63 SHEET 1 PAR 2 ASN A 38 TYR A 40 0 SHEET 2 PAR 2 ILE A 115 LYS A 117 1 O ILE A 115 N PHE A 39 SITE 1 ACT 1 ILE A 79 SITE 1 CA1 2 ASP A 43 GLU A 73 SITE 1 CA2 1 ASP A 85 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000